Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Relevance of monitoring transmural disease activity in patients with Crohn's disease: current status and future perspectives

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pathophysiology and management of diabetic gastroenteropathy

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. A reliability study - strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Keeping It Simple: Using Intestinal Ultrasound to Assess Ulcerative Colitis with a Novel UC-Ultrasound Index

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  3. Bowel stiffness associated with histopathologic scoring of stenosis in patients with Crohn's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Diagnostic accuracy of MRE and ultrasound for Crohn's disease

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • Rune Wilkens
  • Kerri L Novak
  • Christian Maaser
  • Remo Panaccione
  • Torsten Kucharzik
Vis graf over relationer

Treatment targets of inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's disease (CD) have evolved over the last decade. Goals of therapy consisting of symptom control and steroid sparing have shifted to control of disease activity with endoscopic remission being an important endpoint. Unfortunately, this requires ileocolonoscopy, an invasive procedure. Biomarkers [C-reactive protein (CRP) and fecal calprotectin (FCP)] have emerged as surrogates for endoscopic remission and disease activity, but also have limitations. Despite this evolution, we must not lose sight that CD involves transmural inflammation, not fully appreciated with ileocolonoscopy. Therefore, transmural assessment of disease activity by cross-sectional imaging, in particular with magnetic resonance enterography (MRE) and intestinal ultrasonography (IUS), is vital to fully understand disease control. Bowel-wall thickness (BWT) is the cornerstone in assessment of transmural inflammation and BWT normalization, with or without bloodflow normalization, the key element demonstrating resolution of transmural inflammation, namely transmural healing (TH) or transmural remission (TR). In small studies, achievement of TR has been associated with improved long-term clinical outcomes, including reduced hospitalization, surgery, escalation of treatment, and a decrease in clinical relapse over endoscopic remission alone. This review will focus on the existing literature investigating the concept of TR or residual transmural disease and its relation to other existing treatment targets. Current data suggest that TR may be the next logical step in the evolution of treatment targets.

OriginalsprogEngelsk
TidsskriftTherapeutic Advances in Gastroenterology
Vol/bind14
Sider (fra-til)17562848211006672
ISSN1756-283X
DOI
StatusUdgivet - apr. 2021

ID: 65429655